CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 169 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $238,227 | -30.1% | 5,345 | -56.0% | 0.16% | -30.6% |
Q3 2022 | $341,000 | +65.5% | 12,135 | +59.1% | 0.24% | +59.9% |
Q2 2022 | $206,000 | -21.1% | 7,625 | -0.7% | 0.15% | -11.4% |
Q1 2022 | $261,000 | -17.4% | 7,675 | -6.2% | 0.17% | -14.4% |
Q4 2021 | $316,000 | +6.8% | 8,183 | +49.1% | 0.19% | 0.0% |
Q3 2021 | $296,000 | +37.7% | 5,489 | -14.4% | 0.19% | +47.0% |
Q2 2021 | $215,000 | -17.0% | 6,416 | -56.6% | 0.13% | -25.4% |
Q4 2020 | $259,000 | +38.5% | 14,791 | +17.6% | 0.18% | +17.2% |
Q3 2020 | $187,000 | – | 12,581 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |